KRAS and colorectal carcinoma: Statistical significance was determined using Student's t-tests, ANOVA, and survival analysis.<h4>Results</h4>ZBTB20 expression was significantly upregulated with metastatic progression specifically in KRAS-mutant CRC patients and correlated with reduced overall survival.